Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P McLornan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Safety|May 18, 2016
Safety considerations when treating myelofibrosisJ M O'Sullivan, D P McLornan, C N Harrison
Current Research in Translational Medicine|June 18, 2023
Advanced Systemic Mastocytosis with associated haematological neoplasm: Treatment with avapritinib can facilitate successful bridge to allogeneic haematopoietic cell transplantP Sriskandarajah, D P McLornan, C Oni, et al.
International Journal of Laboratory Hematology|May 25, 2010
British Society of Haematology, Slide Session presented at the Annual Scientific Meeting, Brighton 2009D P McLornan, J Burthem, A Duncombe, et al.
Bone Marrow Transplantation|September 9, 2025
Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendationsR Greco, A Ruggeri, D P McLornan, et al.
Bone Marrow Transplantation|November 22, 2023
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMTV Potter, L Gras, L Koster, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Safety|May 18, 2016
Safety considerations when treating myelofibrosisJ M O'Sullivan, D P McLornan, C N Harrison
Current Research in Translational Medicine|June 18, 2023
Advanced Systemic Mastocytosis with associated haematological neoplasm: Treatment with avapritinib can facilitate successful bridge to allogeneic haematopoietic cell transplantP Sriskandarajah, D P McLornan, C Oni, et al.
International Journal of Laboratory Hematology|May 25, 2010
British Society of Haematology, Slide Session presented at the Annual Scientific Meeting, Brighton 2009D P McLornan, J Burthem, A Duncombe, et al.
Bone Marrow Transplantation|September 9, 2025
Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendationsR Greco, A Ruggeri, D P McLornan, et al.
Bone Marrow Transplantation|November 22, 2023
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMTV Potter, L Gras, L Koster, et al.
Pageof 1